About us
Trears Biomarkers is focused on transforming how chronic conditions are detected, monitored, and managed. We develop medical devices and biomarker platforms that capture long-term biological levels, overcoming the limitations of point-in-time blood or saliva testing.
We operate at the intersection of clinical science, diagnostics, and digital health, with applications across metabolic syndrome, cardiovascular risk, stress biology, and other chronic disease pathways. Our company is headquartered in London & Chile and collaborates with academic, clinical, and industry partners in the, highly specialised multidisciplinary team
Business HQ: UK and Chile.
Turnover: Pre-revenue (R&D and validation phase II)
Meet the Team
-
Dr Andres Herane-Vives
FOUNDER & CEO
-
Ms Nelly Pazo-Leon
CLO
-
Ms Myka Asong
EXECUTIVE ASSISTANT & OPERATIONS COORDINATOR
-
Dr Manuel Espinoza
HEALTH ECONOMIST ADVISOR
-
Mr Ismet Dumlupinar
DIGITAL & OPERATIONS ASSISTANT
-
Ms Sophia Skurray
MARKETING COORDINATOR
Our Story
Trears has been developed through collaborations with clinicians, researchers, and innovation programmes in the UK and internationally.
Clinical and scientific validation of novel biomarker approaches [3 peer-review papers]
Participation in MedTech, Innovate UK, innovation accelerator programmes
Collaboration with academic and healthcare stakeholders on chronic disease research
Early engagement with regulators, investors, and healthcare systems regarding adoption pathways
Media & Literature
Why Trears?
Trears is differentiated by its unique biomarker matrix and clinical philosophy:
Proprietary earwax-based biomarker platform enabling long-term biological measurement
Non-invasive, low-burden sampling designed for repeated and real-world use
Strong scientific and clinical grounding, including peer-reviewed validation
Focus on chronic disease monitoring rather than single time-point diagnostics
Zero reported safety incidents across development and testing phases
Sustainability-aligned materials and patient-centric device design
